135 related articles for article (PubMed ID: 2195051)
1. Long-term therapeutic efficacy with once-daily isosorbide-5-mononitrate (Imdur).
Kendall MJ
J Clin Pharm Ther; 1990 Jun; 15(3):169-85. PubMed ID: 2195051
[No Abstract] [Full Text] [Related]
2. Clinical experience with Imdur in angina pectoris. A review.
Nyberg G
Eur J Clin Pharmacol; 1990; 38 Suppl 1():S65-8. PubMed ID: 1972359
[TBL] [Abstract][Full Text] [Related]
3. Experience of long term treatment and different dosage regimens of isosorbide 5-mononitrate.
Meffert M; Paeckelmann IM
Drugs; 1987; 33 Suppl 4():104-10. PubMed ID: 3622314
[TBL] [Abstract][Full Text] [Related]
4. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
Gunasekara NS; Noble S
Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
[TBL] [Abstract][Full Text] [Related]
5. Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.
Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Härkönen R
Drugs; 1987; 33 Suppl 4():118-21. PubMed ID: 2887419
[TBL] [Abstract][Full Text] [Related]
6. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
7. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
[TBL] [Abstract][Full Text] [Related]
8. Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.
Uusitalo A
Drugs; 1987; 33 Suppl 4():111-7. PubMed ID: 2887418
[TBL] [Abstract][Full Text] [Related]
9. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
Walker JM; Curry PV; Bailey AE; Steare SE
Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
Reifart N; Reifart F; Kaltenbach M; Bussmann WD
Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
[No Abstract] [Full Text] [Related]
11. Comments on 'A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily and isosorbide dinitrate twice daily in patients with stable angina'.
Nyberg G
Int J Cardiol; 1997 Jun; 60(1):107-10. PubMed ID: 9209948
[No Abstract] [Full Text] [Related]
12. Is isosorbide mononitrate better than the dinitrate?
Drug Ther Bull; 1984 Jan; 22(2):7-8. PubMed ID: 6363029
[No Abstract] [Full Text] [Related]
13. Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study.
Brun J
J Int Med Res; 1994; 22(5):266-72. PubMed ID: 7867871
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
[TBL] [Abstract][Full Text] [Related]
15. Abrupt withdrawal of isosorbide-5-mononitrate in Durules (Imdur) after long term treatment in patients with stable angina pectoris.
Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Reinikainen P
Eur Heart J; 1988 Dec; 9(12):1339-47. PubMed ID: 3147892
[TBL] [Abstract][Full Text] [Related]
16. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Thadani U
Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
[TBL] [Abstract][Full Text] [Related]
17. Sustained-release isosorbide mononitrate (50 mg): optimization of a once-daily dosage form for long-term treatment of angina pectoris.
Bonn R
Am J Cardiol; 1988 Mar; 61(9):12E-14E. PubMed ID: 3348135
[TBL] [Abstract][Full Text] [Related]
18. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of retard and non-retard forms of isosorbide-5-mononitrate in coronary patients with stable angina pectoris].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Romasiuk SS; Afanas'eva IuV; Naumov VG
Klin Med (Mosk); 2000; 78(11):36-8. PubMed ID: 11232528
[TBL] [Abstract][Full Text] [Related]
20. Extended-release isosorbide mononitrate for angina.
Med Lett Drugs Ther; 1994 Feb; 36(915):13-4. PubMed ID: 8283957
[No Abstract] [Full Text] [Related]
[Next] [New Search]